Value of abdominal susceptibilityweighted magnetic resonance imaging for quantitative assessment of hepatic iron deposition in patients with chronic hepatitis B: Comparison with serum iron markers

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 1005-1015

  Lv, W ^a   Yan, Fuhua ^a,c   Zeng, M ^a   Zhang, J ^b   Yuan, Y ^b   Ma, J ^a  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Dahua Hospital   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chronic hepatitis B; Hepatic iron deposition; Magnetic resonance imaging; Susceptibility weighted imaging

Indexed keywords

FERRITIN; IRON; TRANSFERRIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINA; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEPATITIS B; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IRON BLOOD LEVEL; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SUSCEPTIBILITY WEIGHTED IMAGING; ABDOMEN; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; LIVER; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84863091212     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000319     Document Type: Article

References (27)

1. Maddrey WC: Hepatitis B: an important public health issue. J Med Virol 2000; 61: 362-366.
2. Fujita N, Sugimoto R, Urawa N, et al: Hepatic iron accumulation is associated with disease progression and resistance to interferon/ ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 2007; 22: 1886-1893.
3. Nahon P, Ganne-Carrié N, Trinchet JC, et al: Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis. Gastroenterol Clin Biol 2010; 34: 1-7.
4. Won JE, Jeong SH, Chung JI, et al: Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C. Intervirology 2009; 52: 239-246.
5. Rockey DC, Caldwell SH, Goodman ZD, et al: Liver biopsy. Hepatology 2009; 49: 1018-1041.
6. Mani H, Kleiner DE: Liver biopsy findings in chronic hepatitis B. Hepatology 2009; 49(5 suppl): S61-S71.
7. Emond MJ, Bronner MP, Carlson TH, et al: Quantitative study of the variability of hepatic iron concentrations. Clin Chem 1999; 45: 340-346.
8. Alústiza JM, Artetxe J, Castiella A, et al: MR quantification of hepatic iron concentration. Radiology 2004; 230: 479-484.
9. Chandarana H, Lim RP, Jensen JH, et al: Hepatic iron deposition in patients with liver disease: preliminary experience with breathhold multiecho T2*-weighted sequence. AJR Am J Roentgenol 2009; 193: 1261-1267.
10. Hankins JS, McCarville MB, Loeffler RB, et al: R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009; 113: 4853-4855.
11. Positano V, Salani B, Pepe A, et al: Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging 2009; 27: 188-197.
12. Robinson RJ, Bhuta S: Susceptibility-weighted imaging of the brain: current utility and potential applications. J Neuroimaging 2011; 21: e189-e204.
13. Grabner G, Dal-Bianco A, Schernthaner M, et al: Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J Magn Reson Imaging 2011; 33: 543-549.
14. Zhu WZ, Zhong WD, Wang W, et al: Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009; 253: 497-504.
15. Zhang J, Zhang Y, Wang J, et al: Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res 2010; 1330: 124-130.
16. Dai Y, Zeng M, Li R, et al: Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. J Magn Reson Imaging 2011; 34: 318-325.
17. Ogg RJ, Langston JW, Haacke EM, et al: The correlation between phase shifts in gradientecho MR images and regional brain iron concentration. Magn Reson Imaging 1999; 17: 1141-1148.
18. Haacke EM, Mittal S, Wu Z, et al: Susceptibilityweighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009; 30: 19-30.
19. Deugnier Y, Turlin B: Pathology of hepatic iron overload. World J Gastroenterol 2007; 13: 4755-4760.
20. Abduljalil AM, Schmalbrock P, Novak V, et al: Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultrahigh-field magnetic resonance imaging. J Magn Reson Imaging 2003; 18: 284-290.
21. Deugnier Y, Brissot P, Loréal O: Iron and the liver: update 2008. J Hepatol 2008; 48(suppl 1): S113-S123.
22. Kasvosve I, Delanghe J: Total iron binding capacity and transferrin concentration in the assessment of iron status. Clin Chem Lab Med 2002; 40: 1014-1018.
23. Cao Z, Bai Y, Yang X, et al: Study of iron metabolism abnormality in the hepatocyte damage of hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2001; 9: 37-39.
24. Lee SH, Kim JW, Shin SH, et al: HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population. Dig Dis Sci 2009; 54: 879-886.
25. Bacon BR, Farahvash MJ, Janney CG, et al: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-1109.
26. Mendler MH, Turlin B, Moirand R, et al: Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-1163.
27. Krinsky GA, Lee VS, Nguyen MT, et al: Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 2001; 218: 47-53.